Your browser doesn't support javascript.
loading
Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss.
McFarland, Nikolaus R; Dimant, Hemi; Kibuuka, Laura; Ebrahimi-Fakhari, Darius; Desjardins, Cody A; Danzer, Karin M; Danzer, Michael; Fan, Zhanyun; Schwarzschild, Michael A; Hirst, Warren; McLean, Pamela J.
Afiliação
  • McFarland NR; Center for Translational Research in Neurodegenerative Disease, Department of Neurology, University of Florida, Gainesville, Florida, United States of America.
  • Dimant H; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Kibuuka L; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Ebrahimi-Fakhari D; Division of Neurology and Inherited Metabolic Diseases, Children's Hospital, Heidelberg University Hospital, Ruprecht-Karls University Heidelberg, Heidelberg, Germany.
  • Desjardins CA; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Danzer KM; Deparment of Neurology, Universitatsklinikum Ulm, Ulm, Germany.
  • Danzer M; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Fan Z; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Schwarzschild MA; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America.
  • Hirst W; Pfizer Neuroscience Research Unit, Cambridge, Massachusetts, United States of America.
  • McLean PJ; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
PLoS One ; 9(1): e86048, 2014.
Article em En | MEDLINE | ID: mdl-24465863
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Pirimidinas / Benzamidas / Dopamina / Neostriado / Proteínas de Choque Térmico HSP90 / Alfa-Sinucleína / Ortoaminobenzoatos / Indóis Limite: Animals / Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Pirimidinas / Benzamidas / Dopamina / Neostriado / Proteínas de Choque Térmico HSP90 / Alfa-Sinucleína / Ortoaminobenzoatos / Indóis Limite: Animals / Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos